PAB 0.00% 0.7¢ patrys limited

phase 1, straight to market, page-11

  1. 2,241 Posts.
    lightbulb Created with Sketch. 256
    Very true istria, however I percieve them to be in the same field. Patrys also has a sophisticated business model and a very solid research and development unit. It has recieved accolades from the highest medical institutions for its' research and has been awarded grants for same. As I read Patrys reports their products already work and these clinical trials are to test the efficacy and possible immune system rejection and or danger to a patient. So far it is reported that the process kills cancer cells while not harming normal cells, is not rejected by the immune system and has no side effects.
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $14.40M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $3.875K 553.5K

Buyers (Bids)

No. Vol. Price($)
19 3120846 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 1568171 2
View Market Depth
Last trade - 13.18pm 05/07/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.